Integra Lifesciences Holdings Corp (IART)
27.98
-3.65
(-11.54%)
USD |
NASDAQ |
Apr 19, 15:00
Integra Lifesciences Holdings Cash from Financing (TTM): -229.92M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -229.92M |
| September 30, 2023 | -320.73M |
| June 30, 2023 | -278.72M |
| March 31, 2023 | -281.17M |
| December 31, 2022 | -251.95M |
| September 30, 2022 | -153.73M |
| June 30, 2022 | -144.35M |
| March 31, 2022 | -228.68M |
| December 31, 2021 | -98.23M |
| September 30, 2021 | -77.52M |
| June 30, 2021 | -112.32M |
| March 31, 2021 | -43.40M |
| December 31, 2020 | 121.62M |
| September 30, 2020 | 18.41M |
| June 30, 2020 | 132.48M |
| March 31, 2020 | 147.85M |
| December 31, 2019 | -8.766M |
| September 30, 2019 | -10.83M |
| June 30, 2019 | -131.69M |
| March 31, 2019 | -154.59M |
| December 31, 2018 | -180.87M |
| September 30, 2018 | 567.40M |
| June 30, 2018 | 893.61M |
| March 31, 2018 | 963.02M |
| December 31, 2017 | 1.169B |
| Date | Value |
|---|---|
| September 30, 2017 | 518.50M |
| June 30, 2017 | 212.33M |
| March 31, 2017 | 159.97M |
| December 31, 2016 | -15.12M |
| September 30, 2016 | -46.64M |
| June 30, 2016 | 218.47M |
| March 31, 2016 | 271.92M |
| December 31, 2015 | 248.14M |
| September 30, 2015 | 273.54M |
| June 30, 2015 | 15.04M |
| March 31, 2015 | -18.32M |
| December 31, 2014 | 238.68M |
| September 30, 2014 | 230.56M |
| June 30, 2014 | 243.93M |
| March 31, 2014 | 261.94M |
| December 31, 2013 | 19.02M |
| September 30, 2013 | 22.32M |
| June 30, 2013 | 22.60M |
| March 31, 2013 | 24.57M |
| December 31, 2012 | 11.75M |
| September 30, 2012 | -18.17M |
| June 30, 2012 | 17.74M |
| March 31, 2012 | 92.03M |
| December 31, 2011 | 60.14M |
| September 30, 2011 | 125.92M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-320.73M
Minimum
Sep 2023
147.85M
Maximum
Mar 2020
-102.72M
Average
-112.32M
Median
Jun 2021
Cash from Financing (TTM) Benchmarks
| Stryker Corp | -1.594B |
| OraSure Technologies Inc | -3.023M |
| Insulet Corp | -13.60M |
| PROCEPT BioRobotics Corp | 167.80M |
| Perspective Therapeutics Inc | 0.785M |